- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Vemurafenib + Cobimetinib, Decitabine
Total 3269 results
-
Shanghai Kechow Pharma, Inc.Not yet recruiting
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
Celldex TherapeuticsMemorial Sloan Kettering Cancer CenterCompletedThyroid CancerUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Terminated
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsBelgium, Spain, Germany, Netherlands, Finland
-
Genentech, Inc.CompletedNeoplasms | Bladder Cancer | Solid Tumors | Biliary Cancer | Salivary CancerUnited States
-
Vanderbilt-Ingram Cancer CenterGenentech, Inc.; Stand Up To CancerTerminatedStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Estrogen Receptor-positiveUnited States
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
Piramal Enterprises LimitedMelanoma Research Foundation Breakthrough ConsortiumSuspendedAdvanced or Inoperable Malignant Melanoma With BRAF MutationUnited States
-
Paola QueiroloIstituto Nazionale per lo Studio e la Cura dei TumoriCompletedMalignant Melanoma Stage IVItaly
-
Genentech, Inc.Terminated
-
Hoffmann-La RocheCompletedMultiple Myeloma, NeoplasmsUnited States, China, France, Spain, United Kingdom, Germany
-
Hoffmann-La RocheCompletedLeukemia, Myeloid, AcuteUnited States, Canada, France, Italy
-
Niharika MettuRoche-GenentechWithdrawnMetastatic Colorectal CancerUnited States
-
Clinigen, Inc.Prometheus LaboratoriesTerminatedMetastatic MelanomaUnited States
-
University of California, San FranciscoNovartisCompletedBRAF Mutant Metastatic MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant Melanoma, CancerHungary
-
Oslo University HospitalVestre Viken Hospital Trust; University Hospital of North Norway; Ostfold Hospital... and other collaboratorsRecruitingCancer MetastaticNorway
-
Duke UniversityWithdrawn
-
Peter MacCallum Cancer Centre, AustraliaTerminated
-
PfizerActive, not recruitingMelanomaCanada, United States, Spain, Germany, Korea, Republic of, Australia, Czechia, Netherlands, France, Hungary, United Kingdom, Switzerland, Singapore, Russian Federation, Italy, Japan, Israel, Brazil, Portugal, Mexico, Greece, Argen... and more
-
Cascadian Therapeutics Inc.TerminatedAdvanced BRAF-mutant CancersUnited States
-
Astellas Pharma China, Inc.Terminated
-
CytomX TherapeuticsCompletedLymphoma | Solid TumorUnited States, Netherlands, Poland, Spain, Ukraine, United Kingdom
-
Children's Hospital Medical Center, CincinnatiAstellas Pharma IncCompleted
-
Hoffmann-La RocheFoundation Medicine, Inc.Active, not recruitingCancer of Unknown Primary SiteUnited Kingdom, Korea, Republic of, France, Australia, Germany, Austria, Croatia, Denmark, Finland, Greece, Hungary, Italy, Portugal, Spain, Japan, Brazil, Colombia, Mexico, Romania, Czechia, Norway, Thailand, Switzerland, Turkey, Nethe... and more
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.CompletedMetastatic Colorectal CancerUnited States
-
German Cancer Research CenterRecruiting
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Korea, Republic of, Australia, Canada, Germany, Singapore
-
Hoffmann-La RocheTerminatedAdvanced BRAFV600 Wild-type MelanomaUnited States, Korea, Republic of, Australia, Belgium, France, Russian Federation, Italy, Netherlands, Spain, United Kingdom, Brazil, Poland, Germany, Greece, Hungary
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
University of LouisvilleJames Graham Brown Cancer CenterRecruiting
-
Scripps HealthRecruiting
-
Hanmi Pharmaceutical Company LimitedActive, not recruitingMetastatic Solid Tumor | Locally Advanced Solid TumorKorea, Republic of
-
Chinese PLA General HospitalNavy General Hospital, BeijingUnknownRecurrent Adult Acute Myeloid LeukemiaChina
-
Ulrik LassenGlaxoSmithKline; Pfizer; Roche Pharma AGRecruitingNeoplasms | Cancer | Tumors | NeoplasiaDenmark
-
Mohammed MilhemUniversity of Iowa; Holden Comprehensive Cancer CenterCompletedSarcoma | Pancreatic Ductal AdenocarcinomaUnited States
-
West China HospitalRecruitingBRAF V600E-mutated /MSS Metastatic Colorectal Cancer | Vemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Monoclonal AntibodyChina
-
Hoffmann-La RocheRecruitingNon-Small Cell Lung CancerCanada, Belgium, Korea, Republic of, United States, France, Brazil, China, New Zealand, Israel, Spain, Argentina, Serbia, Mexico, Italy, Japan, Turkey, Taiwan, Costa Rica, Thailand, Australia, Germany, Hong Kong, Netherlands, Peru, Poland, Russian Federation and more
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaSpain, United States, Canada, Germany, Netherlands, France, Italy, United Kingdom, Israel, Australia
-
Hoffmann-La RocheCompletedMultiple MyelomaSpain, Denmark, Netherlands, Sweden, Poland, France, Germany, Czechia, Norway
-
Canadian Cancer Trials GroupBristol-Myers Squibb; Pfizer; Hoffmann-La Roche; AstraZeneca; Seagen Inc.RecruitingLymphoma, Non-Hodgkin | Multiple Myeloma | Advanced Solid TumorsCanada
-
Otsuka Beijing Research InstituteRecruitingMyelodysplastic SyndromesChina
-
Anna RaciborskaMaria Sklodowska-Curie National Research Institute of Oncology; Łukasiewicz... and other collaboratorsRecruiting
-
Hoffmann-La RocheCompleted
-
SanofiCompletedNeoplasm MalignantCanada, United States
-
Philip FriedlanderGenentech, Inc.TerminatedMelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaSouth Africa